These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin. Liliom K; Orosz F; Horváth L; Ovádi J J Immunol Methods; 1991 Sep; 143(1):119-25. PubMed ID: 1919032 [TBL] [Abstract][Full Text] [Related]
8. Interaction of calmodulin with the red cell and its membrane skeleton and with spectrin. Burns NR; Gratzer WB Biochemistry; 1985 Jun; 24(12):3070-4. PubMed ID: 4016086 [TBL] [Abstract][Full Text] [Related]
9. Role of calmodulin in thyroid hormone stimulation in vitro of human erythrocyte Ca2+-ATPase activity. Davis FB; Davis PJ; Blas SD J Clin Invest; 1983 Mar; 71(3):579-86. PubMed ID: 6219128 [TBL] [Abstract][Full Text] [Related]
10. The interaction of a new anti-tumour drug, KAR-2 with calmodulin. Orosz F; Vértessy BG; Salerno C; Crifo C; Capuozzo E; Ovádi J Br J Pharmacol; 1997 Jul; 121(5):955-62. PubMed ID: 9222553 [TBL] [Abstract][Full Text] [Related]
11. Influence of Ca2+ and trifluoperazine on the structure of calmodulin. A 1H-nuclear magnetic resonance study. Krebs J; Carafoli E Eur J Biochem; 1982 Jun; 124(3):619-27. PubMed ID: 7106112 [TBL] [Abstract][Full Text] [Related]
12. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors. Gietzen K; Sadorf I; Bader H Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272 [TBL] [Abstract][Full Text] [Related]
13. The synthesis and reaction of a specific affinity label for the hydrophobic drug-binding domains of calmodulin. Jarrett HW J Biol Chem; 1984 Aug; 259(16):10136-44. PubMed ID: 6547949 [TBL] [Abstract][Full Text] [Related]
14. Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase. Scharff O; Foder B Biochim Biophys Acta; 1984 Apr; 772(1):29-36. PubMed ID: 6231956 [TBL] [Abstract][Full Text] [Related]
15. Calmodulin regulation of Ca2+ transport in human erythrocytes. Larsen FL; Katz S; Roufogalis BD Biochem J; 1981 Nov; 200(2):185-91. PubMed ID: 6122443 [TBL] [Abstract][Full Text] [Related]
16. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes. Agre P; Virshup D; Bennett V J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585 [TBL] [Abstract][Full Text] [Related]
17. Functional properties of peptides derived from seminalplasmin: binding to monospecific anti-seminalplasmin immunoglobulins G and calmodulin. Krauhs E; Preuss KD; Scheit KH Biol Chem Hoppe Seyler; 1990 Feb; 371(2):111-6. PubMed ID: 2334517 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the (Ca2+-Mg2+)ATPase purified by calmodulin-affinity chromatography from bovine aortic smooth muscle. Furukawa K; Nakamura H J Biochem; 1984 Nov; 96(5):1343-50. PubMed ID: 6151947 [TBL] [Abstract][Full Text] [Related]
19. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. Itoh H; Hidaka H J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352 [TBL] [Abstract][Full Text] [Related]
20. Ca2+-dependent high-affinity complex formation between calmodulin and melittin. Comte M; Maulet Y; Cox JA Biochem J; 1983 Jan; 209(1):269-72. PubMed ID: 6847615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]